Author

Katherine E. Chaney

Cincinnati Children's Hospital Medical CenterORCID 0000-0001-5485-2821Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Katherine E. Chaney1 paper · Cincinnati Children's Hospital Medical Center

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alex T. LarssoniD· 1 shared Bryant J. Keller· 1 shared Christopher L. MoerteliD· 1 shared David A. LargaespadaiD· 1 shared Garrett M. DraperiD· 1 shared Gunda I. GeorgiD· 1 shared Kyle Brandon WilliamsiD· 1 shared Minu M. BhuniaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alex T. LarssonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewedOct 1, 2025

Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors

Kyle Brandon Williams, Alex T. Larsson, Bryant J. Keller…·David A. Largaespada

This study identifies 23 compounds that selectively kill NF1-deficient Schwann cells and shows their efficacy in vivo, with synergy when combined with Selumetinib.

11 citationstop 5%

humanexperimental assay

𝕏 PostBluesky